Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Loss of toll-like receptor 3 function improves glucose tolerance and reduces liver steatosis in obese mice.

Wu LH, Huang CC, Adhikarakunnathu S, San Mateo LR, Duffy KE, Rafferty P, Bugelski P, Raymond H, Deutsch H, Picha K, Ward CK, Alexoupolou L, Flavell RA, Mbow ML, Susulic VS.

Metabolism. 2012 Nov;61(11):1633-45. doi: 10.1016/j.metabol.2012.04.015. Epub 2012 May 17.

PMID:
22607770
2.

Lateral clustering of TLR3:dsRNA signaling units revealed by TLR3ecd:3Fabs quaternary structure.

Luo J, Obmolova G, Malia TJ, Wu SJ, Duffy KE, Marion JD, Bell JK, Ge P, Zhou ZH, Teplyakov A, Zhao Y, Lamb RJ, Jordan JL, San Mateo LR, Sweet RW, Gilliland GL.

J Mol Biol. 2012 Aug 3;421(1):112-24. doi: 10.1016/j.jmb.2012.05.006. Epub 2012 May 9.

3.

Novel antagonist antibody to TLR3 blocks poly(I:C)-induced inflammation in vivo and in vitro.

Bunting RA, Duffy KE, Lamb RJ, San Mateo LR, Smalley K, Raymond H, Liu X, Petley T, Fisher J, Beck H, Flavell RA, Alexopoulou L, Ward CK.

Cell Immunol. 2011;267(1):9-16. doi: 10.1016/j.cellimm.2010.10.008. Epub 2010 Nov 2.

PMID:
21092943
4.

Long-term activation of TLR3 by poly(I:C) induces inflammation and impairs lung function in mice.

Stowell NC, Seideman J, Raymond HA, Smalley KA, Lamb RJ, Egenolf DD, Bugelski PJ, Murray LA, Marsters PA, Bunting RA, Flavell RA, Alexopoulou L, San Mateo LR, Griswold DE, Sarisky RT, Mbow ML, Das AM.

Respir Res. 2009 Jun 1;10:43. doi: 10.1186/1465-9921-10-43.

5.

Down modulation of human TLR3 function by a monoclonal antibody.

Duffy KE, Lamb RJ, San Mateo LR, Jordan JL, Canziani G, Brigham-Burke M, Korteweg J, Cunningham M, Beck HS, Carton J, Giles-Komar J, Duchala C, Sarisky RT, Mbow ML.

Cell Immunol. 2007 Aug;248(2):103-14. Epub 2007 Nov 28.

PMID:
18048020
6.

A pathway analysis of poly(I:C)-induced global gene expression change in human peripheral blood mononuclear cells.

Huang CC, Duffy KE, San Mateo LR, Amegadzie BY, Sarisky RT, Mbow ML.

Physiol Genomics. 2006 Jul 12;26(2):125-33. Epub 2006 Mar 22.

7.

Induction of Th1-type immunity and tumor protection with a prostate-specific antigen DNA vaccine.

Marshall DJ, San Mateo LR, Rudnick KA, McCarthy SG, Harris MC, McCauley C, Schantz A, Geng D, Cawood P, Snyder LA.

Cancer Immunol Immunother. 2005 Nov;54(11):1082-94. Epub 2005 Jul 27.

PMID:
16047142
8.

A humoral immune response confers protection against Haemophilus ducreyi infection.

Cole LE, Toffer KL, Fulcher RA, San Mateo LR, Orndorff PE, Kawula TH.

Infect Immun. 2003 Dec;71(12):6971-7.

9.

Activation of antigen-specific CD8 T cells results in minimal killing of bystander bacteria.

Jiang J, Zenewicz LA, San Mateo LR, Lau LL, Shen H.

J Immunol. 2003 Dec 1;171(11):6032-8.

10.

Perforin-mediated CTL cytolysis counteracts direct cell-cell spread of Listeria monocytogenes.

San Mateo LR, Chua MM, Weiss SR, Shen H.

J Immunol. 2002 Nov 1;169(9):5202-8.

11.

A superoxide dismutase C mutant of Haemophilus ducreyi is virulent in human volunteers.

Bong CT, Fortney KR, Katz BP, Hood AF, San Mateo LR, Kawula TH, Spinola SM.

Infect Immun. 2002 Mar;70(3):1367-71.

12.
13.

Immune cells are required for cutaneous ulceration in a swine model of chancroid.

San Mateo LR, Toffer KL, Orndorff PE, Kawula TH.

Infect Immun. 1999 Sep;67(9):4963-7.

14.

The sodA gene of Haemophilus ducreyi encodes a hydrogen peroxide-inhibitable superoxide dismutase.

San Mateo LR, Toffer KL, Kawula TH.

Gene. 1998 Jan 30;207(2):251-7.

PMID:
9511768
15.

Periplasmic copper-zinc superoxide dismutase protects Haemophilus ducreyi from exogenous superoxide.

San Mateo LR, Hobbs MM, Kawula TH.

Mol Microbiol. 1998 Jan;27(2):391-404.

16.

Swine model of Haemophilus ducreyi infection.

Hobbs MM, San Mateo LR, Orndorff PE, Almond G, Kawula TH.

Infect Immun. 1995 Aug;63(8):3094-100.

Supplemental Content

Loading ...
Support Center